Table I.
Characteristics | Value | % |
---|---|---|
Gender | ||
Male | 54 | 62 |
Female | 33 | 38 |
Age (years) | ||
Median | 46 | |
Range | 17–76 | |
WHO pathology classification | ||
I (keratinizing) | 0 | 0 |
II (nonkeratinizig) | 7 | 8 |
III (undifferentiatd) | 80 | 92 |
AJCC group (6th ed.) | ||
Stage I | 0 | 0 |
Stage II | 14 | 16 |
Stage III | 35 | 40 |
Stage IVA or IVB | 38 | 44 |
T stage | ||
T1 | 8 | 9 |
T2 | 27 | 31 |
T3 | 20 | 23 |
T4 | 32 | 37 |
CRT | 73 | 83 |
RT alone | 14 | 16 |
WHO, World Health Organization; AJCC, American Joint Committee on Cancer; CRT, concurrent chemoradiotherapy; RT, radiation therapy.